Tarik Regad
Tarik Regad
Senior Research Fellow
Verified email at ntu.ac.uk - Homepage
Title
Cited by
Cited by
Year
Role and fate of PML nuclear bodies in response to interferon and viral infections
T Regad, MK Chelbi-Alix
Oncogene 20 (49), 7274-7286, 2001
3302001
PML mediates the interferon‐induced antiviral state against a complex retrovirus via its association with the viral transactivator
T Regad, A Saib, V Lallemand‐Breitenbach, PP Pandolfi, MK Chelbi‐Alix
The EMBO journal 20 (13), 3495-3505, 2001
1772001
Targeting RTK signaling pathways in cancer
T Regad
Cancers 7 (3), 1758-1784, 2015
1762015
Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies
D Blondel, T Regad, N Poisson, B Pavie, F Harper, PP Pandolfi, H de Thé, ...
Oncogene 21 (52), 7957-7970, 2002
152*2002
The tumor suppressor Pml regulates cell fate in the developing neocortex
T Regad, C Bellodi, P Nicotera, P Salomoni
Nature neuroscience 12 (2), 132, 2009
1072009
Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: influence in cancer development
F Papaccio, F Paino, T Regad, G Papaccio, V Desiderio, V Tirino
Stem cells translational medicine 6 (12), 2115-2125, 2017
1012017
The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF
T Regad, M Roth, N Bredenkamp, N Illing, N Papalopulu
Nature cell biology 9 (5), 531-540, 2007
932007
Targeting cellular pathways in glioblastoma multiforme
JRD Pearson, T Regad
Signal transduction and targeted therapy 2 (1), 1-11, 2017
662017
SUMOylation promotes PML degradation during encephalomyocarditis virus infection
B El Mchichi, T Regad, MA Maroui, MS Rodriguez, A Aminev, S Gerbaud, ...
Journal of virology 84 (22), 11634-11645, 2010
502010
Molecular and cellular pathogenesis of melanoma initiation and progression
T Regad
Cellular and molecular life sciences 70 (21), 4055-4065, 2013
472013
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo
AJ Linley, MG Mathieu, AK Miles, RC Rees, SEB McArdle, T Regad
Journal of Biological Chemistry 287 (17), 13633-13643, 2012
402012
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
L Mele, F Paino, F Papaccio, T Regad, D Boocock, P Stiuso, A Lombardi, ...
Cell death & disease 9 (5), 1-12, 2018
312018
Cytoplasmic PML promotes TGF-β-associated epithelial–mesenchymal transition and invasion in prostate cancer
ME Buczek, AK Miles, W Green, C Johnson, DJ Boocock, AG Pockley, ...
Oncogene 35 (26), 3465-3475, 2016
302016
HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy
M La Noce, F Paino, L Mele, G Papaccio, T Regad, A Lombardi, ...
Journal of Experimental & Clinical Cancer Research 37 (1), 1-15, 2018
192018
de Thé H, Chelbi-Alix MK. 2001. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator
T Regad, A Saib, V Lallemand-Breitenbach, PP Pandolfi
EMBO J 20 (13), 3495-3505, 2001
192001
The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1
MG Mathieu, AK Miles, M Ahmad, ME Buczek, AG Pockley, RC Rees, ...
Cell death & disease 5 (2), e1061-e1061, 2014
182014
MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer
J Vadakekolathu, SIK Al-Juboori, C Johnson, A Schneider, ME Buczek, ...
Cell death & disease 9 (3), 1-12, 2018
102018
A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma
M Dvorkina, V Nieddu, S Chakelam, A Pezzolo, S Cantilena, AP Leite, ...
Clinical Cancer Research 22 (13), 3398-3409, 2016
62016
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation
L Mele, M la Noce, F Paino, T Regad, S Wagner, D Liccardo, G Papaccio, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 160, 2019
42019
Identification and characterisation of NANOG+/OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines
RM Balahmar, DJ Boocock, C Coveney, S Ray, J Vadakekolathu, ...
Oncotarget 9 (6), 7054, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20